chitosan has been researched along with ginsenosides in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 10 (55.56) | 24.3611 |
| 2020's | 5 (27.78) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, BC; Guo, SW; Li, D; Wang, TS | 1 |
| Chen, XM; Sun, WD; Zhang, LJ; Zhu, JB | 1 |
| Araki, H; Hidaka, N; Sakanaka, M; Suemaru, K; Watanabe, S; Yamaguchi, T | 1 |
| Feng, Z; Han, C; Hu, X; Jin, Y; Wang, X; You, C; Zheng, Y | 1 |
| Jia, XB; Jin, X; Liu, QY; Yu, ZH; Zhang, ZH | 1 |
| Kim, YC; Kim, YJ; Mathiyalagan, R; Subramaniyam, S; Yang, DC | 1 |
| Aravinthan, A; Kim, JH; Kim, NS; Muthukumar, T; Sharmila, J | 1 |
| Gao, J; Gao, S; Lu, L; Tang, W; Wang, X; Xu, M; Zhang, M; Zhang, W; Zhang, Y | 1 |
| Chen, BL; Du, YX; Guo, YH; Xing, QJ; Yu, CQ; Zhao, S | 1 |
| Fan, L; He, H; Mao, S; Wang, X; Zhang, X; Zhang, Y | 1 |
| Cao, Y; Chen, L; Diao, E; Gu, Q; Hu, W; Jiang, Y; Li, X; Liu, J; Liu, T; Luo, Y; Sun, F; Wang, Y; Zhang, J; Zhang, L; Zheng, W; Zhou, J | 1 |
| Cai, H; Liu, C; Shang, W; Shen, J; Xu, Z; Zhang, B; Zhao, Z | 1 |
| Chinh, NT; Giang, LD; Hoang, T; Loc, TT; Mai, TT; Ramadass, K; Thang, VV; Tuan, TM | 1 |
| Adithan, A; Hossain, MA; Hwang, KC; John Peter, JS; Khang, G; Kim, JH; Kim, NS; Thangavelu, M | 1 |
| Chen, J; Gu, Q; Hu, W; Jiang, Y; Li, W; Li, Y; Shang, Z; Shen, T; Wang, W; Zhang, J; Zhou, J | 1 |
| Gao, W; Han, X; Huang, L; Ji, H; Li, X; Li, Z; Liu, C; Man, S; Pecoraro, L; Qiao, O; Wang, J; Wang, W; Zhang, X; Zhang, Y | 1 |
| Abid, S; Balusamy, SR; Kaliraj, L; Kang, SC; Kim, YJ; Rahimi, S; Yang, DC | 1 |
| Choi, HS; Kim, YJ; Mi, XJ; Park, HR | 1 |
18 other study(ies) available for chitosan and ginsenosides
| Article | Year |
|---|---|
[Study on process of removing impurity from water-extraction of gutianquan-capsule].
Topics: Animals; Capsules; Chitin; Chitosan; Coumaric Acids; Drug Combinations; Drug Contamination; Drug Stability; Drugs, Chinese Herbal; Ginsenosides; Mantodea; Materia Medica; Panax; Plants, Medicinal; Technology, Pharmaceutical | 2003 |
[Effect of absorption enhancers on nasal ginsenoside Rg1 delivery and its nasal ciliotoxicity].
Topics: Absorption; Administration, Intranasal; Animals; Bufo bufo; Camphanes; Chitosan; Cilia; Deoxycholic Acid; Drug Synergism; Female; Ginsenosides; Male; Mice; Mice, Inbred ICR; Nasal Mucosa; Rabbits; Rats; Rats, Sprague-Dawley | 2006 |
Effect of oral mucosal adhesive films containing ginsenoside Rb1 on 5-fluorouracil-induced oral mucositis in hamsters.
Topics: Adhesives; Administration, Topical; Alginates; Animals; Antineoplastic Agents; Chitosan; Cricetinae; Fluorouracil; Ginsenosides; Glucuronic Acid; Hexuronic Acids; Mouth Mucosa; Peroxidase; Stomatitis | 2009 |
In vitro evaluation of Panax notoginseng Rg1 released from collagen/chitosan-gelatin microsphere scaffolds for angiogenesis.
Topics: Apoptosis; Cell Cycle; Cell Movement; Cell Proliferation; Chitosan; Collagen; Dose-Response Relationship, Drug; Drug Carriers; Gelatin; Gene Expression Regulation; Ginsenosides; Human Umbilical Vein Endothelial Cells; Humans; Kinetics; Microspheres; Neovascularization, Physiologic; Panax notoginseng; Vascular Endothelial Growth Factor A | 2013 |
[Study on preparation and in vitro characteristics of ginsenoside Rg3 binary solid dispersion].
Topics: Chitosan; Drug Compounding; Ginsenosides; Molecular Weight; Poloxamer; Solvents | 2013 |
Ginsenoside compound K-bearing glycol chitosan conjugates: synthesis, physicochemical characterization, and in vitro biological studies.
Topics: Buffers; Cell Survival; Chemistry Techniques, Synthetic; Chitosan; Drug Delivery Systems; Drug Stability; Ginsenosides; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Nanoparticles; Particle Size | 2014 |
Collagen/chitosan porous bone tissue engineering composite scaffold incorporated with Ginseng compound K.
Topics: Animals; Cattle; Cell Line, Tumor; Chitosan; Collagen; Ginsenosides; Humans; Materials Testing; Mice; NIH 3T3 Cells; Tibia; Tissue Engineering; Tissue Scaffolds | 2016 |
Intranasal Delivery of Microspheres Loaded with 20 (R)-ginsenoside Rg3 Enhances Anti-Fatigue Effect in Mice.
Topics: Administration, Intranasal; Animals; Chitosan; Drug Delivery Systems; Fatigue; Female; Ginsenosides; Male; Mice; Microspheres; Nasal Mucosa; Particle Size; Rats, Sprague-Dawley | 2017 |
Effects of ginsenoside Rg1-loaded alginate-chitosan microspheres on human bone marrow stromal cells.
Topics: Alginates; Cell Differentiation; Cell Proliferation; Cells, Cultured; Chitosan; Drug Carriers; Drugs, Chinese Herbal; Ginsenosides; Glucuronic Acid; Hexuronic Acids; Humans; Mesenchymal Stem Cells; Neuroprotective Agents; Particle Size | 2017 |
Influence of polymeric carrier on the disposition and retention of 20(R)-ginsenoside-rg3-loaded swellable microparticles in the lung.
Topics: A549 Cells; Adhesiveness; Animals; Bronchoalveolar Lavage Fluid; Cell Survival; Cellulose; Chitosan; Drug Carriers; Drug Liberation; Ginsenosides; Humans; Hyaluronic Acid; Intestinal Mucosa; Jejunum; Lung; Macrophages; Male; Mice; Molecular Weight; Particle Size; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells | 2018 |
Enhanced cytotoxic and apoptotic potential in hepatic carcinoma cells of chitosan nanoparticles loaded with ginsenoside compound K.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Survival; Chitosan; Deoxycholic Acid; Drug Carriers; Drug Liberation; Ginsenosides; Hep G2 Cells; Humans; Liver Neoplasms; Nanoparticles | 2018 |
Fabrication and evaluation a transferrin receptor targeting nano-drug carrier for cerebral infarction treatment.
Topics: Animals; Apoptosis; Blood-Brain Barrier; Cell Hypoxia; Cerebral Infarction; Chitosan; Drug Carriers; Ginsenosides; Male; Maleimides; Microvessels; Molecular Targeted Therapy; Nanostructures; Polyglutamic Acid; Rats; Rats, Sprague-Dawley; Receptors, Transferrin | 2019 |
Novel Drug Delivery System Based on Ginsenoside Rb1 Loaded to Chitosan/Alginate Nanocomposite Films.
Topics: Alginates; Chitosan; Drug Delivery Systems; Ginsenosides; Nanocomposites; Spectroscopy, Fourier Transform Infrared | 2019 |
Ginseng compound K incorporated porous Chitosan/biphasic calcium phosphate composite microsphere for bone regeneration.
Topics: Animals; Bone Regeneration; Cell Survival; Chitosan; Collagen Type I; DNA; Gene Expression Regulation; Ginsenosides; Humans; Hydroxyapatites; Mesenchymal Stem Cells; Mice; Microspheres; NIH 3T3 Cells; Osteocalcin; Osteopontin; Porosity; Rats, Sprague-Dawley; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2020 |
Micelles modified with a chitosan-derived homing peptide for targeted intracellular delivery of ginsenoside compound K to liver cancer cells.
Topics: Apoptosis; Cell Proliferation; Chitosan; Cytoplasm; Drug Delivery Systems; Ginsenosides; Hep G2 Cells; Humans; Liver Neoplasms; Micelles; Peptides; Polyethylene Glycols | 2020 |
Nanoparticle conjugation of ginsenoside Rb3 inhibits myocardial fibrosis by regulating PPARα pathway.
Topics: Animals; Biological Availability; Cardiomyopathies; Chitosan; Drug Carriers; Drug Compounding; Energy Metabolism; Fibrosis; Ginsenosides; Male; Molecular Docking Simulation; Myocardium; Nanoparticles; Panax; Polyphosphates; PPAR alpha; Rats; Rats, Sprague-Dawley; Signal Transduction | 2021 |
Synthesis and characterization of glycol chitosan coated selenium nanoparticles acts synergistically to alleviate oxidative stress and increase ginsenoside content in Panax ginseng.
Topics: Biosynthetic Pathways; Chitosan; Genes, Plant; Ginsenosides; Nanoparticles; Oxidative Stress; Panax; Reactive Oxygen Species; Selenium; Up-Regulation | 2021 |
Structural characterization and anti-inflammatory properties of green synthesized chitosan/compound K‑gold nanoparticles.
Topics: Anti-Inflammatory Agents; Chitosan; Ginsenosides; Gold; Metal Nanoparticles | 2022 |